IEFM
ARCT icon

IQ EQ Fund Management’s Arcturus Therapeutics ARCT Stock Holding History

IQ EQ Fund Management’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$849K Buy
126,390
+12,135
+11% +$95.7K 0.05% 237
2026
Q1 		$882K Buy
114,255
+22,679
+25% +$165K 0.07% 220
2025
Q4 		$561K Buy
91,576
+47,599
+108% +$514K 0.04% 246
2025
Q3 		$810K Buy
43,977
+18,592
+73% +$299K 0.05% 233
2025
Q2 		$330K Buy
25,385
+10,188
+67% +$120K 0.03% 268
2025
Q1 		$161K Buy
+15,197
New +$241K 0.02% 288

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

IQ EQ Fund Management's ARCT Position: Q2 2026 in Review

IQ EQ Fund Management increased its Arcturus Therapeutics (ARCT) stake by 11% in Q2 2026, buying an estimated $95.7K and bringing the position to 126,390 shares worth $849K. The position accounts for 0.05% of the portfolio, ranked #237.

IQ EQ Fund Management first reported a position in ARCT in Q1 2025 and has held it in 6 quarters since. The position peaked at $882K in Q1 2026. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • IQ EQ Fund Management held 126,390 shares of Arcturus Therapeutics worth $849K as of Q2 2026.
  • IQ EQ Fund Management bought 12,135 Arcturus Therapeutics shares in Q2 2026, an estimated $95.7K.
  • Arcturus Therapeutics made up 0.05% of IQ EQ Fund Management's portfolio in Q2 2026, its #237 holding.
  • IQ EQ Fund Management first reported a position in Arcturus Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • IQ EQ Fund Management's Arcturus Therapeutics position peaked at $882K in Q1 2026.
  • 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on IQ EQ Fund Management's 13F filing for Q2 2026, filed 31 Jul 2026.